A phase I/II study of siltuximab (CNTO) an anti-interleukin-6 monoclonal antibody in metastatic renal cell cancer

JF Rossi, S Negrier, ND James, I Kocak, R Hawkins, H Davis, U Prabhakar, X Qin, P Mulders, B Berns

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)1154-1162
    Number of pages8
    JournalBr J Cancer
    Issue number6
    Publication statusPublished - 2010

    Cite this